Healthcare provider profile · identity verified

Heidi Sult Thomas, MD

Internal Medicine · SALEM, OR · NPI 1356342091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	227	54
Atorvastatin Calcium	Atorvastatin Calcium	190	47
Rosuvastatin Calcium	Rosuvastatin Calcium	164	49
Omeprazole	Omeprazole	155	39
Gabapentin	Gabapentin	143	28
Trazodone Hcl	Trazodone Hcl	141	27
Amlodipine Besylate	Amlodipine Besylate	139	33
Sertraline Hcl	Sertraline Hcl	130	29
Bupropion Xl	Bupropion Hcl	123	32
Lisinopril	Lisinopril	123	31
Oxycodone Hcl	Oxycodone Hcl	121	25
Metoprolol Succinate	Metoprolol Succinate	108	29
Clonazepam	Clonazepam	87	18
Duloxetine Hcl	Duloxetine Hcl	85	16
Losartan Potassium	Losartan Potassium	77	23
Metformin Hcl	Metformin Hcl	76	20
Ezetimibe	Ezetimibe	70	20
Alendronate Sodium	Alendronate Sodium	69	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	15
Ozempic	Semaglutide	65	15
Citalopram Hbr	Citalopram Hydrobromide	59	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	23
Eliquis	Apixaban	56	13
Estradiol	Estradiol	54	18
Furosemide	Furosemide	54	16
Pantoprazole Sodium	Pantoprazole Sodium	53	15
Escitalopram Oxalate	Escitalopram Oxalate	52	17
Donepezil Hcl	Donepezil Hcl	50	12
Olmesartan Medoxomil	Olmesartan Medoxomil	50	16
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	15
Fluoxetine Hcl	Fluoxetine Hcl	43	11
Montelukast Sodium	Montelukast Sodium	43	11
Carvedilol	Carvedilol	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	suppressed
Propranolol Hcl	Propranolol Hcl	37	14
Prednisone	Prednisone	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Meloxicam	Meloxicam	33	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Metformin Hcl Er	Metformin Hcl	31	12
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	29	suppressed
Ondansetron Odt	Ondansetron	29	14
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Risperidone	Risperidone	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Eszopiclone	Eszopiclone	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Liothyronine Sodium	Liothyronine Sodium	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Diazepam	Diazepam	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Folic Acid	Folic Acid	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Famotidine	Famotidine	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Nurtec Odt	Rimegepant Sulfate	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Valsartan	Valsartan	16	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nitroglycerin	Nitroglycerin	15	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Azithromycin	Azithromycin	14	13
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Torsemide	Torsemide	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Restasis	Cyclosporine	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Modafinil	Modafinil	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error